Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$19,531,384
+$17,289,028 QoQ
Shares Held
811,104
+915.7% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#292
of 2,821 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arax Advisory Partners holds $367,571,362 across 18 Drug Manufacturers - General names. PFE ranks #7 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
326,790 | $82,994,856 | |
| 2 | MRK |
Merck & Co., Inc.
|
608,608 | $78,206,128 | |
| 3 | LLY |
ELI LILLY & Co
|
46,821 | $56,158,516 | |
| 4 | ABBV |
AbbVie Inc.
|
164,897 | $41,494,681 | |
| 5 | NVO |
Novo Nordisk A S
|
449,006 | $21,525,347 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
363,882 | $20,966,880 | |
| 7 | PFE |
Pfizer Inc
This page
|
811,104 | $19,531,384 | |
| 8 | AMGN |
Amgen Inc
|
50,310 | $18,218,257 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,531,384 | 811,104 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,242,356 | 79,856 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,843,147 | 74,022 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,000,232 | 156,995 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $753,767 | 31,096 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $538,144 | 21,237 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,034,059 | 38,977 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $282,106 | 9,748 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $258,506 | 9,239 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $234,542 | 8,452 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $239,647 | 8,324 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $328,481 | 9,903 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $396,180 | 10,801 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $604,288 | 14,811 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $767,523 | 14,979 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $650,186 | 14,858 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $713,991 | 13,618 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $693,718 | 13,400 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $778,633 | 13,186 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $316,166 | 7,351 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $268,089 | 6,846 | Shares | Sole | 2021-08-02 | |
| 2020-12-31 | $383,044 | 10,406 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $379,807 | 10,349 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $237,663 | 7,268 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $342,393 | 10,490 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||